Tag: AstraZeneca
UK regulator approves dapagliflozin for use in heart failure across the full spectrum of left ventricular ejection fraction
AstraZeneca has today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) ...
FARXIGA meets primary endpoint in Phase III DAPA-HF trial
AstraZeneca has announced positive results from the Phase III DAPA-HF trial which showed that FA...
Orodispersible tablets of ticagrelor now available in the UK
AstraZeneca has announced the UK availability of ticagrelor (Brilique) 90mg orodispersible tablets. ...
NICE recommends dual antiplatelet therapy with ticagrelor and aspirin
The National Institute of Health and Care Excellence (NICE) has published a final appraisal determin...
